Skip to content

Author

J. S. Park

2 papers indexed here

We haven’t gathered this author’s papers yet. Follow them and we’ll fetch their work.

Not the right person? Other researchers publish under this name.

Review Open access Sep 2026

Clinical benefit of adjuvant chemotherapy in resected T2N0 distal cholangiocarcinoma: a retrospective cohort study

Purpose Several studies have reported that adjuvant chemotherapy (AC) improves survival outcomes in patients with distal cholangiocarcinoma (dCCA). However, definitive evidence supporting the efficacy of AC in dCCA patients with early T-stage and node-negative disease remains lacking. This study aimed to investigate th...

Y. Chae, Youngmin Han, Seulah Park et al. · 0 citations
Sep 2026

Abstract B064: xCT promotes SMAD signaling to induce gemcitabine resistance in KRAS-mutated pancreatic cancer

KRAS mutations are highly prevalent in pancreatic ductal adenocarcinoma (PDAC), leading to poor prognosis. Although gemcitabine is mainly utilized as the first-line treatment, patients with PDAC often develop resistance. However, the underlying mechanism of gemcitabine resistance in KRAS-mutant PDAC remains unclear....

J. S. Park · 0 citations

We use cookies to run the site and, with your consent, for analytics and to show ads. See our Cookie Policy.